Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-31 Purchase |
2024-02-01 6:32 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
4,000 | $2.3813 | $9,525 | 27,478 (Direct) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:37 pm |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
10,000 | $2.7 | $27,000 | 20,000 (Indirect) |
View |
| 2024-01-30 Purchase |
2024-01-31 4:34 pm |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
8,000 | $2.693 | $21,544 | 34,969 (Indirect Direct) |
View |
| 2023-06-12 Purchase |
2023-06-12 4:31 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
40,000 | $0.8 | $32,000 | 1,676,691 (Indirect Direct) |
View |
| 2023-04-14 Purchase |
2023-04-14 6:16 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
20,000 | $0.5499 | $10,998 | 1,636,691 (Indirect Direct) |
View |
| 2023-04-11 Purchase |
2023-04-13 4:51 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
60,000 | $0.48333 | $29,000 | 1,616,691 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-21 Other |
2023-11-28 4:13 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
55,267 | $0 | 594,619 (Indirect) |
View |
| 2023-10-12 Option Award(A) |
2023-10-23 5:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
6,000 | $0.3 | 594,619 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:07 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
14,771 | $0.34 | 369,208 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
100,000 | $0.25 | 200,000 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 6:01 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
5,000 | $0.32 | 469,535 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:58 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
15,000 | $0.33 | 99,250 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:56 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
6,000 | $0.3 | 595,619 (Direct) |
View |
| 2023-10-12 Option Award |
2023-10-12 5:54 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner |
155,277 | $0.29 | 1,973,968 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 5:05 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
4,500 | $0.21 | 57,613 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 5:03 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Pres. Research & Development 10% Owner |
142,000 | $0.24 | 1,818,691 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 5:00 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
13,700 | $0.21 | 464,535 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 4:58 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
12,000 | $0.21 | 589,619 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 4:56 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
100,000 | $0.25 | 100,000 (Direct) |
View |
| 2023-10-10 Option Award |
2023-10-10 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
22,500 | $0.24 | 84,250 (Direct) |
View |
| 2023-08-08 Option Award |
2023-08-09 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Ng George K Chief Executive Officer |
800,000 | $0 | 1,200,000 (Direct) |
View |
| 2023-06-27 Exercise |
2023-07-24 6:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Neal James R Director |
14,407 | $0 | 115,772 (Direct) |
View |
| 2023-06-27 Option Award |
2023-07-24 6:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Neal James R Director |
101,365 | $0 | 115,772 (Direct) |
View |
| 2023-06-27 Exercise |
2023-07-24 6:35 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
23,636 | $0 | 677,984 (Direct) |
View |
| 2023-06-27 Option Award |
2023-07-24 6:35 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
101,365 | $0 | 677,984 (Direct) |
View |
| 2023-06-27 Exercise |
2023-07-24 6:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
23,636 | $0 | 241,907 (Direct) |
View |
| 2023-06-27 Option Award |
2023-07-24 6:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
101,365 | $0 | 241,907 (Direct) |
View |
| 2023-06-27 Exercise |
2023-07-24 6:29 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director |
15,455 | $0 | 129,320 (Direct) |
View |
| 2023-06-27 Option Award |
2023-07-24 6:29 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director |
101,365 | $0 | 129,320 (Direct) |
View |
| 2023-06-27 Exercise |
2023-07-24 6:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
23,636 | $0 | 154,478 (Direct) |
View |
| 2023-06-27 Option Award |
2023-07-24 6:26 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
101,365 | $0 | 154,478 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
10,000 | $0.8 | 172,061 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:20 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
12,500 | $0.8 | 61,750 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:18 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Baluch Khoso Director |
12,500 | $0.8 | 12,500 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
12,500 | $0.8 | 450,835 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-10 5:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
18,750 | $0.8 | 1,556,691 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 5:49 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
48,208 | $0 | 595,656 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:47 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
106,648 | $0 | 1,184,497 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
106,648 | $0 | 1,184,497 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:43 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
106,648 | $0 | 1,184,497 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:42 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
178,768 | $0 | 1,293,326 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:39 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David President & CEO 10% Owner |
49,380 | $0 | 824,716 (Direct) |
View |
| 2022-12-31 Option Award |
2023-01-04 5:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
138,248 | $0 | 1,268,533 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-04 5:36 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
18,208 | $0 | 146,906 (Indirect) |
View |
| 2023-01-01 Option Award |
2023-01-04 5:36 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
30,000 | $0 | 146,906 (Direct) |
View |